A single dose of Oxford-AstraZeneca or Pfizer-BioNTech’s Covid-19 vaccine drastically reduces the risk of infection in adults of all ages, British researchers have found. Two studies released on Friday analyzed more than 1.6 million nose and throat swabs taken from 373,402 people between December and April. The data was collected as part of the ongoing […] Read more
Controversy over AstraZeneca’s Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it’s not all bad news for the British pharmaceutical company. Australia, the Philippines and the African Union have become the latest to either curb or abandon planned purchases of the Oxford University-AstraZeneca coronavirus shot due to possible links to […] Read more
The coronavirus vaccine developed by Pfizer-BioNTech is likely to be just as effective against a highly transmissible mutant strain of the virus that was discovered in the U.K., according to a study by the two companies. The variant, known as B.1.1.7., was estimated to have first emerged in the U.K. in September. It has an unusually high […] Read more
Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19 — a result CEO Stephane Bancel called a “game-changer.” The analysis evaluated 95 confirmed Covid-19 infections among the trial’s 30,000 participants. Moderna, which developed its vaccine in collaboration with the National Institute of Allergy and Infectious Diseases, said 90 […] Read more
The discovery of a new coronavirus strain on Danish mink farms has led to the introduction of strict public health measures in the north of the country, with other European nations also responding to the outbreak. It comes after a warning from Denmark’s national authority for the control of infectious disease, the State Serum Institute, that if […] Read more
